Roche Holding Ltd

As of June 30, 2026, Roche Holding Ltd carries a market capitalization of 296.72B, placing it among publicly traded companies globally. Its enterprise value stands at 324.99B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Roche Holding Ltd has 796.77M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Roche Holding Ltd maintains a current ratio of 1.23, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 6, 2026, Roche Holding Ltd's stock has gained approximately 19.88% over the past 52 weeks. The 50-day moving average sits at 393.60, while the 200-day moving average is 376.91.

As of June 30, 2026, Roche Holding Ltd holds 10.55B in cash and equivalents against 34.46B in total debt, resulting in a net debt position of 28.56B. Total book value stands at 35.42B, with working capital of 7.14B providing operational flexibility.

Roche Holding Ltd's most recent stock split took place on May 4, 2001 with a 1:100 split ratio.